Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.86
|
1.87
|
1.79
|
1.75
|
1.875
|
1.86
|
|
|
114 449.61
|
283.00
|
1.77
|
1.82
|
1.77
|
1.735
|
1.825
|
1.755
|
|
|
180 237.58
|
397.00
|
1.74
|
1.81
|
1.74
|
1.72
|
1.795
|
1.73
|
|
|
50 998.52
|
154.00
|
1.75
|
1.77
|
1.75
|
1.72
|
1.77
|
1.75
|
|
|
59 448.96
|
203.00
|
1.75
|
1.77
|
1.705
|
1.70
|
1.745
|
1.74
|
|
|
66 739.00
|
217.00
|
1.71
|
1.78
|
1.73
|
1.70
|
1.74
|
1.72
|
|
|
49 224.26
|
170.00
|
1.76
|
1.84
|
1.78
|
1.74
|
1.79
|
1.77
|
|
|
44 553.59
|
158.00
|
1.74
|
1.86
|
1.80
|
1.775
|
1.895
|
1.785
|
|
|
94 408.04
|
322.00
|
1.73
|
1.80
|
1.72
|
1.695
|
1.84
|
1.78
|
|
|
133 115.82
|
316.00
|
1.73
|
1.81
|
1.75
|
1.695
|
1.76
|
1.74
|
|
|
181 172.50
|
440.00
|
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology.